擅長領域：糖尿病并發(fā)癥的治療?

執(zhí)業(yè)經歷： 職 稱：副主任醫(yī)師 　　職 務：臨床醫(yī)師 　　院 區(qū)：浦東仁濟 　　科 室：內分泌科 　　醫(yī)療專長： 醫(yī)療專長：2006年獲澳大利亞政府獎學金于澳大利亞阿德雷德大學醫(yī)學院攻讀醫(yī)學博士學位，2010年畢業(yè)回國,現(xiàn)于上海交通大學仁濟醫(yī)院內分泌科工作。 　　門診時間：每周四下午 　　教育經歷 　　畢業(yè)于澳大利亞阿德雷德大學醫(yī)學院 　　學術職務 　　上海內分泌學會青年委員 　　論文著作 　　1)Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes.Young RL, Chia B, Isaacs NJ, Ma J, Khoo J, Wu T, Horowitz M, Rayner CK.Diabetes. 2013 Oct;62(10):3532-41. 　　2)A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes. Ma J, Checklin HL, Wishart JM, Stevens JE, Jones KL, Horowitz M, Meyer JH, Rayner CK.Diabetologia. 2013 Jun;56(6):1236-42. 　　3)Dehydroepiandrosterone-sulfate (DHEAS) promotes MIN6 cells insulin secretion via inhibition of AMP-activated protein kinase. Yue J, Wang L, Huang R, Li S, Ma J, Teng X, Liu W. Biochem Biophys Res Commun. 2013 Nov 1;440(4):756-61. 　　4)Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes. Ma J, Pilichiewicz AN, Feinle-Bisset C, Wishart JM, Jones KL, Horowitz M, Rayner CK. Diabet Med. 2012 May;29(5):604-8. 　　5)Comment on: Chen et al. Utilizing the second-meal effect in type 2 diabetes: practical use of a soya-yogurt snack. Diabetes Care 2010;33:2552-2554. Rayner CK, Ma J, Jones KL, Horowitz M. Diabetes Care. 2011 May;34(5):e55; author reply e56. doi: 10.2337/dc11-0195. Erratum in: Diabetes Care. 2011 Aug;34(8):1887. 　　6)Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects. Ma J, Chang J, Checklin HL, Young RL, Jones KL, Horowitz M, Rayner CK. Br J Nutr. 2010 Sep;104(6):803-6. doi: 10.1017/S0007114510001327. Epub 2010 Apr 27. 　　7)Effects of cefaclor on gastric emptying and cholecystokinin release in healthy humans. Ma J, Bellon M, Wishart JM, Young RL, Jones KL, Horowitz M, Rayner CK. Regul Pept. 2010 Jan 8;159(1-3):156-9. 　　8)Insulin secretion in healthy subjects and patients with Type 2 diabetes--role of the gastrointestinal tract. Ma J, Rayner CK, Jones KL, Horowitz M. Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):413-24. Review. 　　9)Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, Clifton PM, Horowitz M, Rayner CK. Diabetes Care. 2009 Sep;32(9):1600-2. 　　10)Diabetic gastroparesis: diagnosis and management. Ma J, Rayner CK, Jones KL,Horowitz M. Drugs. 2009 May 29;69(8):971-86. Review. 　　11)Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL, Horowitz M, Rayner CK. Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G735-9. 詳細介紹